Maxwell Plus

The founder of one of Main Sequence’s first investments, medtech Maxwell Plus, on failure, timing, and being ahead of the pack

A retrospective on Maxwell Plus, a machine-vision prostate cancer medtech that folded, with founder Elliot Smith and investor Phil Morle sharing lessons; Harrison.ai's later raise underscores the timing they missed.

Also Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Forbes Australia·Forbes Australia

Maxwell Plus - Lessons Learned

Main Sequence reflects on Maxwell Plus, an early machine-vision healthcare bet it made in 2017 and later wound up, with founder and investor each sharing candid go-to-market and hiring lessons from the failure.

Also Startup Daily

Brisbane's Maxwell Plus is using artificial intelligence to help clinicians diagnose and flag risk of disease

Profile of Brisbane AI health startup Maxwell Plus, which recalls a $3.4 million raise led by Main Sequence Ventures and a $1.1 million government grant for Alzheimer's detection work.